Modified release hydrocortisone, a new treatment for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a single center 'real-world evidence' preliminary study
Key Points
Key points are not available for this paper at this time.
Abstract
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
Modified release hydrocortisone, a new treatment for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a single center 'real-world evidence' preliminary study | Synapse